ZENITHDRUG
Start SIP
Invest Now
Start SIP in ZENITHDRUG
Zenith Drugs Performance
- Low
- ₹48
- High
- ₹51
- 52 Week Low
- ₹45
- 52 Week High
- ₹107
- Open Price₹48
- Previous Close₹48
- Volume16,800
- 50 DMA₹50.10
- 100 DMA₹54.12
- 200 DMA₹60.67
Investment Returns
- Over 1 Month + 4.26%
- Over 3 Month -9.26%
- Over 6 Month -32.88%
- Over 1 Year -29.14%
Smart Investing Starts Here Start SIP with Zenith Drugs for Steady Growth!
Zenith Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.7
- PEG Ratio
- -
- Market Cap Cr
- 84
- P/B Ratio
- 1.2
- Average True Range
- 3
- EPS
- 4.26
- Dividend Yield
- 0
- MACD Signal
- -0.75
- RSI
- 51.29
- MFI
- 67.48
Zenith Drugs Financials
Zenith Drugs Technicals
EMA & SMA
Current Price
₹49.00
+
0.75
(1.55%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹48.21
- 50 Day
- ₹50.10
- 100 Day
- ₹54.12
- 200 Day
- ₹60.67
Resistance and Support
49.17
- R3 54.33
- R2 52.67
- R1 50.83
- S1 47.33
- S2 45.67
- S3 43.83
Zenith Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-05-29 | Audited Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-04-17 | To consider Fund Raising & Others | To consider Other business matters. (Revised) Final Dividend of Re. 0.5 per equity share |
| 2024-11-14 | Quarterly Results | |
| 2024-05-29 | Audited Results |
Zenith Drugs F&O
About Zenith Drugs
- NSE Symbol
- ZENITHDRUG
- BSE Symbol
- Managing Director
- Mr. Sandeep Bhardwaj
- ISIN
- INE0QWN01013
Similar Stocks to Zenith Drugs
Zenith Drugs FAQs
Zenith Drugs share price is ₹49 As on 26 February, 2026 | 04:18
The Market Cap of Zenith Drugs is ₹84 Cr As on 26 February, 2026 | 04:18
The P/E ratio of Zenith Drugs is 11.7 As on 26 February, 2026 | 04:18
The PB ratio of Zenith Drugs is 1.2 As on 26 February, 2026 | 04:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.